Table 5 Clinical characteristics of colorectal cancer with a negative FIT(of group 2) vs Group 1
From: Impact of the faecal immunochemical test on colorectal cancer survival
UNIVARIATE ANALYSIS | MULTIVARIATE ANALISIS | ||||
|---|---|---|---|---|---|
GROUP 1 N = 279 N (%) | NEGATIVE FIT (of group 2) N = 49 N (%) | P | OR | 95% CI | |
AGE (years) | |||||
≤ 49 | 13 (4.7) | 1 (2) | |||
50–69 | 74 (26.5) | 17 (34.7) | 0.4 | ||
≥ 70 | 192(68.8) | 31 (63.3) | |||
SEX | |||||
Men | 177(63.4) | 24 (49) | 0.05 | 1 | |
Women | 102(36.6) | 25 (51) | 1.8 | 0.95–3,4 | |
SITES | |||||
Rectum | 67 (24.0) | 5 (10.2) | 1 | ||
Distal | 115(41.2) | 17 (34.7) | 0.03 | 2.01 | 0.70–5.78 |
Proximal | 94(33.7) | 24 (49.0) | 3.57 | 1.27–10.03 | |
Unknown | 3(1.1) | 3(6.1) | |||
HISTOLOGY | |||||
Adenocarcinoma | 267(95.7) | 46 (93.9) | |||
Mucinous adenocarcinoma | 7 (2.5) | 2 (4.1) | 0.8 | ||
Othersa | 5 (1.8) | 1(2) | |||
STAGE | |||||
Stage I | 51 (18.3) | 3 (6.1) | 1 | ||
Stage II | 92(33) | 18 (36.7) | 0.18 | 2.87 | 0.79–10.4 |
Stage III | 64(22.9) | 15 (30.6) | 4.1 | 1.10–15.36 | |
Stage IV | 72 (25.8) | 13 (26.5) | 2.82 | 0.74–10.69 | |
Overall 3-year survival | 72% | 63% | 0.5 | ||